Detalles de la búsqueda
1.
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials.
Br J Dermatol
; 190(5): 668-679, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38226713
2.
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.
Ann Rheum Dis
; 77(12): 1710-1719, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30269054
3.
Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.
Rheumatology (Oxford)
; 56(9): 1484-1491, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28482054
4.
Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.
Clin Exp Rheumatol
; 34(5): 893-900, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27383049
5.
Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.
Rheumatol Int
; 35(9): 1489-95, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25794569
6.
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the ß-Confident Registry.
RMD Open
; 7(2)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001647
7.
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.
Arthritis Rheumatol
; 72(12): 2147-2158, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648697
Resultados
1 -
7
de 7
1
Próxima >
>>